Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sadhana Sundararajan, Keerthana Karunakaran & Rajiniraja Muniyan. (2023) Structure based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Shahab Zomorodbakhsh, Yasamin Abbasian, Maryam Naghinejad & Mojgan Sheikhpour. (2020) The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis. International Journal of Nanomedicine 15, pages 5901-5909.
Read now
Read now
Sameer Hassan, Vaishnavi Sudhakar, M. Benita Nancy Mary, Rajeshwari Babu, Mukesh Doble, Maryam Dadar & Luke Elizabeth Hanna. (2020) Computational approach identifies protein off-targets for Isoniazid-NAD adduct: hypothesizing a possible drug resistance mechanism in Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics 38:6, pages 1697-1710.
Read now
Read now
Surya Narayan Rath, Lingaraja Jena & Manorama Patri. (2020) Understanding ligands driven mechanism of wild and mutant aryl hydrocarbon receptor in presence of phytochemicals combating Parkinson’s disease: an in silico and in vivo study. Journal of Biomolecular Structure and Dynamics 38:3, pages 807-826.
Read now
Read now
Hourieh Kalhor, Solmaz Sadeghi, Mahya Marashiyan, Reyhaneh Kalhor, Sanaz Aghaei Gharehbolagh, Mohammad Reza Akbari Eidgahi & Hamzeh Rahimi. (2020) Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches. Journal of Biomolecular Structure and Dynamics 38:3, pages 791-806.
Read now
Read now
Articles from other publishers (8)
Mehran Ebrahimi Shah-abadi, Armin Ariaei, Fatemeh Moradi, Auob Rustamzadeh, Rastegar Rahmani Tanha, Nader Sadigh, Mohsen Marzban, Mahdi Heydari & Vahid Tavakolian Ferdousie. (2023) In Silico Interactions of Natural and Synthetic Compounds with Key Proteins Involved in Alzheimer’s Disease: Prospects for Designing New Therapeutics Compound. Neurotoxicity Research 41:5, pages 408-430.
Crossref
Crossref
Abdolreza Esmaeilzadeh, Davood Jafari, Mahnaz Ghaebi, Reza Elahi, Farideh Afshari & Leila Karimi. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
45
.
Kirsten E. Knoll, Mietha M. van der Walt & Du Toit Loots. (2022)
In Silico
Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis
. Microbiology Spectrum.
Crossref
Crossref
Surya Narayan Rath, Lingaraja Jena, Rajabrata Bhuyan, Nimai Charan Mahanandia & Manorama Patri. (2021) In silico discovery and evaluation of phytochemicals binding mechanism against human catechol-O-methyltransferase as a putative bioenhancer of L-DOPA therapy in Parkinson disease. Genomics & Informatics 19:1, pages e7.
Crossref
Crossref
Iqrar Ahmad, Harsha Jadhav, Yashodeep Shinde, Vilas Jagtap, Rukaiyya Girase & Harun Patel. (2021) Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors. In Silico Pharmacology 9:1.
Crossref
Crossref
Alina Minias, Lidia Żukowska, Ewelina Lechowicz, Filip Gąsior, Agnieszka Knast, Sabina Podlewska, Daria Zygała & Jarosław Dziadek. (2021) Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era. Frontiers in Microbiology 11.
Crossref
Crossref
Kuanxia Ma, Lushan Liang, Xie Zhou, Weiguo Tan, Ou Hu & Zuanguang Chen. (2021) A Redox-induced Dual-mode Colorimetric and Fluorometric Method based on N-CDs and MnO2 for Determination of Isoniazid in Tablets and Plasma Samples. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 247, pages 119097.
Crossref
Crossref
Manisha Ray, Saurav Sarkar & Surya Narayan Rath. (2020) Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2. Genomics & Informatics 18:4, pages e43.
Crossref
Crossref